AAAAAA
Results:
1-13
|
Results: 13
Authors:
RUHLMANN J
OEHR P
BENDER H
KOZAK B
WILLKOMM P
BECHTOLD V
LIND P
BIERSACK HJ
Citation: J. Ruhlmann et al., TOXICITY AND RADIATION-DOSE OF 2-[F-18]-2 -DEOXY-D-GLUCOSE DURING POSITRON-EMISSION-TOMOGRAPHY, Acta medica austriaca, 25(1), 1998, pp. 1-6
Authors:
OEHR P
RUHLMANN J
RINK H
Citation: P. Oehr et al., 18F-FDG UPTAKE IN-VITRO - RELATION TO GLUCOSE-CONCENTRATION AND RADIATION-DOSE, The Journal of nuclear medicine, 39(5), 1998, pp. 852-852
Authors:
VACATA V
OEHR P
RINK H
RUHLMANN J
Citation: V. Vacata et al., COMPUTER MODELING OF TUMOR-GROWTH AND TREATMENT, Journal of tumor marker oncology, 12(4), 1997, pp. 37-40
Authors:
OEHR P
RINK H
VACATA V
RUHLMANN J
Citation: P. Oehr et al., TPS IN HELA-TISSUE CULTURE IS NOT A PROLIFERATION MARKER, Journal of tumor marker oncology, 12(4), 1997, pp. 41-45
Authors:
RUHLMANN J
OEHR P
BENDER H
KOZAK B
WILLKOMM P
SCHRADER M
BIERSACK HJ
Citation: J. Ruhlmann et al., PET IN DAILY ROUTINE FOR DIAGNOSTICS OF B REAST-CANCER, Acta medica austriaca, 24(2), 1997, pp. 63-67
Authors:
OEHR P
VACATA V
RUHLMANN J
RINK H
Citation: P. Oehr et al., COMPUTER MODELING OF CYTOKERATIN RELEASE IN CLINICAL ONCOLOGY, Anticancer research, 17(4B), 1997, pp. 3111-3112
Authors:
RUHLMANN J
SCHOMBURG A
BENDER H
OEHR P
ROBERTZVAUPEL GM
VAUPEL H
WOLTER H
KOZAK B
BIERSACK HJ
Citation: J. Ruhlmann et al., FLUORODEOXYGLUCOSE WHOLE-BODY POSITRON-EMISSION-TOMOGRAPHY IN COLORECTAL-CANCER PATIENTS STUDIED IN ROUTINE DAILY PRACTICE, Diseases of the colon & rectum, 40(10), 1997, pp. 1195-1204
Authors:
HALIM AB
ELAHMADY O
EISSA S
BADARY OA
AGHA A
OEHR P
Citation: Ab. Halim et al., DOES TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN (TPS) RELATE TO TISSUE POLYPEPTIDE ANTIGEN (TPA) IN EHRLICH ASCITES-CARCINOMA (EAC)-BEARING MICE, Journal of tumor marker oncology, 11(3), 1996, pp. 23-28
Authors:
HALIM AB
ELAHMADY O
HAMZA S
ABOULELA M
OEHR P
Citation: Ab. Halim et al., CAN WE USE A MORNING URINE SAMPLE INSTEAD OF 24-HOUR URINE FOR THE DETERMINATION OF TUMOR-MARKERS IN EGYPTIAN BLADDER-CANCER, Journal of tumor marker oncology, 9(4), 1994, pp. 47-52
Authors:
SCHULTES BC
REINSBERG J
SCHLEBUSCH H
OEHR P
BIERSACK HJ
KREBS D
WAGNER U
Citation: Bc. Schultes et al., IDIOTYPIC CASCADES AFTER INJECTION OF THE MONOCLONAL-ANTIBODY OC125 -A STUDY IN A MOUSE MODEL - INDUCTION OF ANTIBODIES AGAINST OC125 AND CA-125 AFTER IMMUNIZATION WITH AN ANTI-CA-125 (MAB OC125) MONOCLONAL-ANTIBODY BY ACTIVATION OF THE IDIOTYPIC NETWORK, European journal of clinical chemistry and clinical biochemistry, 31(7), 1993, pp. 427-432
PALLIATIVE THERAPY OF LOCAL RECURRENCE IN BREAST-CANCER USING ANTIBODY-TARGETED PHOTODYNAMIC THERAPY
Authors:
SCHMIDT S
WAGNER U
OEHR P
KREBS D
Citation: S. Schmidt et al., PALLIATIVE THERAPY OF LOCAL RECURRENCE IN BREAST-CANCER USING ANTIBODY-TARGETED PHOTODYNAMIC THERAPY, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 445-446
Authors:
WAGNER U
CHRONIDES A
MALLMANN P
REINSBERG J
SCHULTES B
CUI H
LIU Q
OEHR P
SCHMOLLING J
SCHLEBUSCH H
SCHMIDT S
BIERSACK HJ
KREBS D
Citation: U. Wagner et al., INDUCTION OF A TUMOR-SPECIFIC CELLULAR-IM MUNITY BY IDIOTYPE-VACCINATION WITH THE MAB OC 125 FOR PATIENTS WITH OVARIAN CARCINOMAS, Tumordiagnostik & Therapie, 14(4), 1993, pp. 125-131
Authors:
KENEMANS P
VANKAMP GJ
OEHR P
VERSTRAETEN RA
Citation: P. Kenemans et al., HETEROLOGOUS DOUBLE-DETERMINANT IMMUNORADIOMETRIC ASSAY CA-125-II - RELIABLE 2ND-GENERATION IMMUNOASSAY FOR DETERMINING CA-125 IN SERUM, Clinical chemistry, 39(12), 1993, pp. 2509-2513
Risultati:
1-13
|